Sg3 Management, LLC Aclaris Therapeutics, Inc. Transaction History
Sg3 Management, LLC
- $0
- Q3 2023
A detailed history of Sg3 Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Sg3 Management, LLC holds 58,200 shares of ACRS stock, worth $222,324. This represents 0.04% of its overall portfolio holdings.
Number of Shares
58,200Holding current value
$222,324% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ACRS
# of Institutions
84Shares Held
50.7MCall Options Held
30.6KPut Options Held
1K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$54.4 Million9.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.69MShares$17.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.37MShares$12.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.01MShares$11.5 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$10.5 Million0.11% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $255M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...